4

PRIMARY DOCUMENT

Company: RHYTHM PHARMACEUTICALS, INC.
Filed: October 6, 2017
Period of Report: October 5, 2017
Accession Number: 0001638599-17-001008

View Document ↗ View on SEC.gov ↗